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Abstract 
Reconstruction of maxillofacial continuity defects has always 
been a challenging tasks for the scientist and surgeons over the 
years. The main goal of the reconstruction of the maxillofacial 
region is to restore facial form, function, full rehabilitation of 
occlusion and articulation. A refinement in surgical technique 
and methods of reconstruction has improved patient’s quality of 
life. This manuscript reviewed exciting methods of bone 
reconstruction and confirms that the ideal system for 
reconstruction of critical size continuity defect of the jaw bones 
has yet to be found. Shortcoming and limitation of each method 
has been discussed. The author highlight recent advances on 
how tissue engineering which could offer biological substitute to 
restore, maintain, or improve oro-facial function. 
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Introduction 
Maxillofacial bone defects are caused by 
cancer resections, followed by trauma, 
clefts, burns, and infection.  Reconstruction 
of maxillofacial bone defects has been 
observed throughout recorded history. 
Human beings have found the need to 
reconstruct missing or defective 
maxillofacial parts — such as eyes, ears, 
noses, maxilla, mandible and teeth — with 
artificial substitutes .  Reconstruction to 
reconstruct large bony defects in the 
maxillofacial region remains a major 
surgical challenge. The size of the defect 
and the effect of radiation therapy ( in case 
of cancer treatment) on the blood supply of 
the surrounding tissues are the main limiting 
factors of successful reconstruction. 1]. 
Sykoff performed the first surgical attempt 
for maxillofacial reconstruction, most of the 
published data were based on an expert 
opinion, and the studies provided only 
limited objective guidelines for successful 
treatment [2]. The surgical techniques for 
facial reconstruction were regional, 
historical, and individual bases for use 
rather than evolving and evidence based.  In 
addition, researchers did not agree on clear 
outcome measures for comparative studies 
[2].  Assessment of function, aesthetic and 
quality life assessments of reconstruction 
techniques are needed to be standardized to 
allow reconstruction of maxillofacial bone 
defects rational and robust. This paper 
reviews current techniques available for 
reconstruction of continuity defect in 
maxillofacial region based on human trials 
and highlights the advantages and 
disadvantages of each method 
Free bone grafts 
The autogenous bone graft has been a 
satisfactory technique for osteoconduction, 
osteoinduction and osteogenesis. 
Osteoconduction occurs when the bone graft 
material serves as a scaffold for new bone 
growth that is perpetuated by the native 
bone. Osteoinduction involves the 
stimulation of osteoprogenitor cells to 
differentiate into osteoblasts that then begin 
new bone formation. The most widely 
studied type of osteoinductive cell 
mediators are bone morphogenic protein 
(BMPs). Osteogenesis occurs when vital 
osteoblasts originating from the bone graft 
material contribute to new bone growth 
along with bone formation generated via the 
other two mechanisms (osteoconduction and 
osteoinduction).  At present, many surgeons 
choose a cortico-cancellous block graft 
taken from the anterior or posterior iliac 
crest for jaw reconstruction. The success of 
these grafts is probably much dependent on 
the way the bone is fixed because the 
survival depends of the graft largely on 
revascularization from the recipient site [3]. 
This revascularization is of paramount 
importance for the process of resorption and 
deposition of new bone that is known as 
creeping substitution. However, there are 
two major limitation of using an autogenous 
bone graft: poor osteointegration and 
excessive resorption when the defect is 
larger than 6 to 9 cm. Insufficient blood 
supply for the surrounding tissues secondary 
to irradiation, scarring, and infection is 
major detrimental factor. Moreover, donor 
site morbidity limits the use of autogenous 
bone graft [4].  
Particulate cancellous bone marrow graft 
(PBCM) 
Since 1944, reconstruction of long bone has 
been demonstrated using PBCM. This 
method of grafting has been proved to attain 
superior osteogenic potential and lower rate 
of surgical complication compared to 
cortical graft[5] . Due to the inherent lack of 
cohesion, the PBCM graft was placed in a 
frame or crib to maintain its physical 
dimensions, and to provide a mechanical 
stability. Titanium, vitallium, tantalum, 
chrome cobalt and stainless steel metal cribs 
were frequently used to deliver the PBCM 
[6-9]. These metal trays had clean 
disadvantage, especially for the patients 
who would be subjected to radiotherapy 
later. In addition, it has higher modulus of 
elasticity compared to bone resulting in tray 
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absorbing much of the functional stress 
(stress shielding effect) which causes 
resorption to the supporting bone [3]. To 
overcome the drawback of metal trays,  
dacron- coated poly- urethene trays are 
beeing used for reconstruction of human 
mandible [9, 10]. Complication are reported  
even with the use of metal or dacron tray 
like  wound dehiscence, and postoperative 
infection. Thus introduction of resorbable 
alloplastic trays to the world of 
maxillofacial reconstruction has attracted 
attention of many researcher to test it is 
feasibility before the clinical application 
[11, 12]. Apart from alloplastic cribs, a 
freeze dried allogenic mandibular tray filled 
with PBCM has been used in clinical trials 
and the tested trays have showed success in 
restoring form, shape and function in more 
than 80% of the cases [13, 14]. Major 
limitation of this technique was the lack of 
availability. The use the patient`s own 
mandible after scrubbing the diseased part 
from bone was also used as a crib to hold 
PBCM for reconstruction. The bone crib 
was autoclaved or freeze dryad before being 
filled with PBCM.  These atttemps have 
showed variable rate of success in animal 
and human trials [15, 16].   
Furthermore, the use of plasma rich protein 
and PBCM has been tested for the 
reconstruction of continuity defect of the 
mandible in animal model and in clinical 
trials [17-20]. The reported advantages of 
PBCM grafts are the potential to create an 
anatomic mandibular reconstruction of 
adequate height, symmetrical arch form and 
width, and the ability to adequately support 
dental implants. Moreover, this type of graft 
has proved its ability to bridge large 
mandibular defect of any length [16,3]. 
Paradoxically, the main reported 
disadvantage included the resorption, and 
wound dehiscence which may lead to loss of 
the graft [16]. The later was the main reason 
why PBCM grafts are not recommended in 
patients with malignant tumours where scar 
fibrosis and lack of vascularity which affect 
the covering soft tissues [3]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-1: Illustration demonstrate the objective of bone bioengineering is to develop a 
biomimetic construct which consists of osteognic cells (Stem cells), growth factor (BMP) and 
scaffolding (bone cement), all will lead to chemoattaraction and angiogenesis when implanted in 
vivo which ultimately lead to complete bone regeneration 
 
Pedicled composite grafts 
It is a graft that composed of bone, muscle 
or skin, and with their feeding blood vessels 
(vein and artery). To overcome the problem 
of vascularity of free bone graft, the use of 
pedicle bone and composite graft become 
more popular in the field maxillofacial 
reconstruction.  The most commonly used  
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is the pedicle scapula flap for maxillofacial 
reconstruction. Many techniques have been 
advocated and their feasibility has been 
investigated. Surgeon reported successful 
results in clinical trial [21-23] where this 
technique is used. Nevertheless, some 
obvious drawbacks of using different flaps 
were reported. Pedicle composite flap based 
on sternocleidomastoid muscle may not be 
always possible.  Moreover, the aesthetic 
results of pedicle bone graft were not 
always acceptable [3]. Furthermore, these 
techniques are also associated with donor 
site morbidity [24]. 
Microvascular free flap transfer 
At present mandibular reconstruction using 
microvascular free flaps is the gold 
standard, as it provides, in most cases, a 
satisfactory functional reconstruction [25].  
In a prospective study, irradiated mandible 
was reconstructed using free vascular bone 
graft, cases were followed up for 10 year 
and a 90% success rate was reported [26]. 
However, shaping of microvascular bone 
graft to restore complex 3-dimensional 
orbitomaxillary defects is requires greter 
expertise [25]. Furthermore, iliac crest free 
vascular flap, which is the most common 
microvascular flap has a short vascular 
pedicle and the lack of segmental 
perforating vessels limits its use [27]. In 
contrary, fibula flap has reported widest 
application, it can provide up to 30 cm of 
bone with adequate length and diameter of 
the feeder vessels [26, 28]. However, pre-
existing peripheral vascular disease will 
preclude use of this flap. Another limitation 
for fibula flap was inadequate height in 
relation to the jaw bone to be restored [29]. 
A similar limitation has been also reported 
with the use of radius forearm 
microvascular flap for maxillofacial 
reconstruction [30]. 
Tissue engineering and regenerative 
medicine  
Tissue engineering was initially introduced 
to describe the technology producing 
biological tissue in vitro [31]. Recently, the 
term regenerative medicine has been used to 
describe the development of technology and 
surgical procedures for the regeneration of 
tissue in vivo [31]. The working goal of 
tissue engineering is the implementation of 
existing knowledge for the creation of a 
product (tissue) that can resemble 
autogenous tissue and able to act as a 
substitute for any lost tissue at any point in 
time. The objectives of tissue engineering 
and regenerative medicine are to promote 
healing and ideally to simulate true 
regeneration of a tissue structure and 
function more predictably, and to be less 
invasive than previous grafting techniques. 
Advances in research have shown that the 
tissue engineering and design of the scaffold 
matrices, and the mechanical signals that 
regulate engineered tissues, have an 
important role for successful tissue 
bioengineering, the use of three-dimensional 
biomaterial scaffolds to support 
regeneration and to substitute autograft is 
essential. Numerous scaffolds matrices, 
including allogenic, xenogenic, and 
synthetic graft materials have been available 
on the market for use in oral surgical 
procedures and orthopedics surgery. The 
exact mechanism of the action of these 
matrices is to provide foundation for cells to 
migrate from the wound edges, eventually 
leading to the repair of the defect. The 
principle disadvantage of using scaffold 
without cells or cytokinas is lack of 
osteoinductive properties and osteogenesis. 
In addition the rate of resoption of some 
types of allograft scaffolding mismatched 
the rate of the new bone formation leading 
to failure of integrating the bioengineered 
tissue with the surrounding bone. A review 
by Neovius E and Engstrand T, (2009) 
compared the commonly used biomaterial 
and bone graft or combination in non-load- 
bearing areas  for craniofacial reconstruction 
for 11 years from 83 studies. The study 
concluded that, significant difference in 
outcome were mainly related to size and 
location of defects rather than bio-material 
used [32]. 
The major turn point in the arena of bone 
reconstruction is the introduction of Bone 
Morphogenic Proteins (BMP). BMP’s are 
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cytokines which are produced by variety of 
cells and can be produced biologically in 
large quantities and are available 
commercially. They stimulate osteoinuction, 
thus inducing osteoprogentor cell to produce 
bone, and resulting in a chemo-attraction for 
the mesenchymal stem cells to the defect 
area [33]. At the level of preclinical animal 
research, the use of BMP reported 
promising results [34-36]. Few cases were 
published on successful reconstruction of 
the maxillofacial region in clinical trials 
[37-40]. Two prospective longitudinal 
control clinical trials were carried out using 
BMP and scaffolds [38-33].  Herford et al  
2007 tested the feasibility of bone 
morphogenic protein in repairing a 
premaxillary cleft. Twelve patients were 
selected in this study [39]. The planned 
procedure was to repair the oral-nasal fistula 
and to graft the alveolar cleft with BMP-2 
delivered into type-1 bovine collagen 
sponge carrier. The surgery was performed 
by a surgeon, two patients were grafted 
using particulate marrow cancellous bone 
and were considered as control. The cases 
were evaluated pre-surgery and 4 month 
postoperatively by computed tomography 
(CT). A special imaging protocol 
(computer-assisted software IMPAX) was 
followed to measure the volume of the 
defect and measurement of bone filling after 
grafting. Result showed that the mean bone 
volume ratio preoperative to postoperative 
was 71.7% in the BMP-2cases whereas, 
preoperative to postoperative mean volume 
ratio was 78.1% for the control group. The 
author concluded that BMP-2 is an effective 
alternative to conventional grafting 
technique.  
On the same vein, (Ferretti et al, 2002) 
tested bone regeneration in mandibular 
critical continuity defect of human with 
naturally derived BMPs, and this was 
compared with autologous bone grafts [39]. 
The BMP was delivered on a scaffolding of 
human cortical bone chips.  Data from the 
morphometric analysis for the successful 
BMP graft had highly active osteogenesis 
compared with autogenous bone graft 
group. Despite the failure to induce bone in 
four of the constructs, the author concluded 
the study was a successful introduction of 
this novel approach to repair critical 
mandibular defect through extraction of 
BMPs from the natural milieu of bovine 
bone matrix that preclude the need to 
harvest autologous bone. Although there is 
definitely a future for engineered graft using 
BMP, the long term effect of this material 
on various tissue cells and its oncogenic 
effect not yet determined. Another factor 
related is the costs involved in using the 
commercially available BMP which 
preclude their use on large scale [3]. In 
systematic review by Herford et al, (2011) 
for the use of BMP in reconstruction of the 
jaw, it was concluded that with the reported 
failure rate for the used growth factors in 
clinical trial was 13.9%, therefore, it is not 
possible to conclude that BMP can replace 
the need for autognous bone grafts [41]. 
Another dimension of bone tissue 
engineering is the use of prefabricated 
bioengineered bone flaps. Kokemueller et 
al, 2010 conducted a study to determine the 
effectiveness of the implantation procedure 
and the role of the vascular axial perfusion 
for a large bioartificial scaffold on bone 
formation [42]. Twenty-four cylindrical tri-
calcium phosphate (β-TCP) scaffolds (25 
mm long) were intraoperatively filled with 
bone marrow harvest prepared in special 
way to maximise their osteogenic potential 
and implanted into back muscle in an 
animal trial. The successful results of this 
pre-clinicl animal trial on sheep has 
encouraged the researchers for clinical 
application by preparation of construct with 
the same technique, then implanted into a 
continuity jaw defect. Similarly, Warnke et 
al  (2004) reported a novel method of 
repairing a human mandible by in vivo 
tissue engineering. Bone morphogenic 
protein-7 (rhBMP-7) and bone marrow-
derived mesenchymal stem cells were added 
to a bioresorbable polylactite scaffold, 
which was loaded in a titanium mesh tray as 
an external scaffold [43].  The patient 
served as his own bioreactor, as the titanium 
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mesh was grown inside the patient’s 
latissimus dorsi muscle.  After seven weeks 
the formed bone with titanium mesh was 
transplanted to the patient’s mandible.  The 
results showed greater osteoblastic activity 
and marked bone formation were detected in 
all parts of the mandible during the 38th 
week. The authors concluded that 
transplantation could have been performed 
at a later stage, as osteoblast activity and 
bone remodelling remained highly active 
during the first 8 months.   
Another successful reconstruction of the 
mandible was recorded by Warnke and his 
coworkers (2006) [44].  They reported a 
patient who underwent a secondary 
reconstruction after tumor resection. The 
engineered graft was allowed to heal in the 
trapezius muscle and subsequently 
transplanted to the recipient side in 
mandible. The graft was anastmosed to the 
recipient side and the outcome of this study 
were encouraging.  
An important human trial aiming to 
maintain sustainable blood supply to the 
graft was conducted by using perfabricated 
tissue engineeried graft which was 
transfered in a pedicaled flaps. Heliotis et al, 
(2006), demonstrated the preparation of 
vascularised bone flap extra-skeletally, with 
combination of osteogenic protein-1 (OP-1) 
and hydroxyapatite HA flap used for 
reconstruction of large mandibular defect in 
human [45]. A 60 year old patient presented 
with hemimandible as a result of previous 
surgical resection of malignant tumor. The 
patient underwent radiotherapy 
postoperatively and no reconstruction of the 
jaw was performed. Three blocks of HA 
were adjusted to the shape of the 
mandibular body and ramus, OP-1 was 
smeared over the blocks and then implanted 
within the pectoralis major muscle for 15 
weeks. Skeletal scintigraphy was performed 
to assess bone formation on the graft 
material. The implanted composite was 
raised with attached muscle leaving it 
pedicaled to thoracoacromial artery for 
mandibular reconstruction. Then it was 
fixed externally to left side of the mandible, 
after certain preparation for soft tissue bed 
on the mandible, the pedicle was covered by 
free skin graft. An external fixation device 
was used to secure the graft in place and to 
prevent unwanted movement. Radiographs 
were taken which reported a reasonable 
anatomical position of the graft. Despite the 
initial success of the technique after, 5 
months patient developed MRSA infection 
at the graft site. Subsequently, the bone 
graft was immediately removed. In spite of 
the reported success of use of BMP, yet it`s 
uses need further improvement and studies 
for the reconstruction of large complex 
defect in cranio-maxillofacial region [32]. 
Bone Mesenchymal Stem Cells (BMSCs) 
Bone mesenchymal stem cells (BMSCs) 
were introduced in the repair of large bony 
defects during the last decade. Several 
studies investigated the use of expanded 
BMSCs which were seeded on various 
scaffolds in animal models. Variable degree 
of success was reported [46-50]. The basic 
principle of tissue engineering involves a 
“triad” wherein a combination of cells in a 
suitably engineered material scaffold with 
appropriate biochemical signals is used to 
provide viable therapeutic options for 
clinical applications. Advances in research 
have shown that the engineering and design 
of the scaffold matrices, and the mechanical 
signals that regulate engineered tissues, 
have an important role [51] (Figure-1). The 
rationale behind the use of Mesenchymal 
stem cell into scaffolds with/or without PRP 
or BMP is to achieve osteogenesis, 
osteoconductivity, osteopromotion and 
osteoinductivity. The advantage of using 
stem cell for reconstruction is that they have 
inherent multipotetial properties i.e. they 
can differentiate into different cell lineages, 
if these cells have been induced to follow 
the osteogenic lineague using BMP, would 
stimulate vascular in growth from the 
recipient bed. Furthermore it has been 
proved that bone formed using this 
technique is more likely to respond 
appropriately to secondary surgical 
intervention e.g. distruction osteogenesis. In 
contrary bone graft from ribs or fibula 
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respond poorly to second surgery 
manipulation [52]. To date, one clinical trial 
by Lee et al, (2010) reported a successful 
reconstruction of 15 cm segmental 
mandibular defect using bone marrow stem 
cells [16]. Following a segmental 
mandibulectomy jaw bone were fixed using 
reconstruction plates. The resected jaw was 
freeze - dried for 48 hours and was 
perforated using surgical burs. At the same 
time, autogenous bone marrow stem cells 
were aspirated, isolated and cultured in vitro 
before load onto the bone segment 
immediately prior to the surgical 
implantation. One year postoperatively, the 
mandible showed excellent clinical and 
radiographic evidence of bone regeneration.  
Another idea introduced to maxillofacial 
reconstruction is the In Situ Osteogenesis 
(ISO) which is based on creation of 
periosteum chamber and implantation of 
BMP into the chamber [40]. The use of 
osteoprogentor cells in combination with 
alloplast/or allograft and gowth factors were 
studied extensively in literature and reported  
different success  rate. The problem with 
cell seeding and  its survival  depend on 
vascularity of the construct. Most of 
research have used osteoprogintor cells and 
reported less promising result claimed that 
lack of vasculartiy could be the cause [53, 
54, 50]. Therefore the idea of using 
autognous pedical muscle flap could 
overcome the point of lack of vascularty as 
the muscle will act as bioreactor for the 
introduced biomimitic bone cement and the 
rMSCs.  Similar concept was reported a 
promicing  result when muscle used to 
reconstruct cranial defect in rats (Liu et al, 
2011 ) [53]. 
Molecular therapy 
The popularity of using molecular therapy 
in regenerative medicine, has led to 
emergence of intricate research in cranio-
facial region. The idea of having sustained 
release of growth factors which was the 
fundamental premise of using molecular 
therapy and genetic engineering is of great 
interest [55, 56]. Moreover, providing a dual 
action of transfected MSCs and and vascular 
induce factor with BMP-2 gene was 
introduced and justified by He X, (2013) 
[57]. Another use of molecular therapy is to 
enhance endogenous cell mechanism 
recruitment to regenerate injured bone by 
local targeting and activation of 
Sphingosing-1-phosphate (S1P) receptors 
[58]. Molecular therapy urges the scientist 
to evaluate the ability of genetically 
modified, autologous muscle to heal large 
cranial defects in rats [53].  The effect of 
hypoxia induced factor-1α (HIF- 1α) gene 
on osteogenesis of BMSCs using point 
mutant technique was explored by Zou et al, 
2011[59].  Furthermore, the term antibody-
mediated osseous regeneration (AMOR) 
was recently introduced to tissue 
engineering research. Ansari S et al, (2013) 
have assessed the efficacy of newly 
generated chimeric anti-BMP-2 monoclonal 
antibodies (mAb) in mediating AMOR as 
well as evaluating the suitability of different 
biomaterials as scaffolds to participate in 
AMOR [60]. Conclusion 
Surgeons are tirelessly working to 
reconstruct continuity defect in 
maxillofacial region for more than a 
century. Enormous progress has made 
especially over the last 40 years .Technique 
such as microvascular autogenous graft 
procedures have proved better options for 
reconstructing large and complex defects, 
but morbidity associated with harvesting 
bone graft is a major disadvantage. 
Alternatively, use of tissue engineering 
showed exciting promising results at pre-
clinical level and in the limited clinical trial. 
Yet refinement of the technique and 
identification of the ideal scaffolding are 
necessary before wider clinical application. 
Further studies are required to produce an 
evidence based practice in tissue 
bioengineering clinically. This could have 
significant impact on the reconstruction of 
maxillofacial defects due to bone loss 
following trauma or cancer resection.  
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